Navigation Links
UBC researchers devise new technology to monitor brain aneurysms
Date:11/4/2011

University of British Columbia researchers have developed new technology for monitoring brain aneurysms an approach that is potentially less invasive and more accurate than current methods, and one that is simple enough for patients to use at home for frequent monitoring.

Brain aneurysms occur when the weak wall of an artery carrying blood to the brain begins to bulge and balloon out. If the artery ruptures, the hemorrhage can lead to stroke, brain damage or death. To create a plug that will prevent blood flow to the weak area of the artery, surgeons typically insert an "embolization" implant made of microscopic coils of platinum.

UBC researchers have now devised a monitoring technique that is compatible with existing coil-implantation tools and procedures. In the first study of its kind, the team proved that it is possible to use the platinum implant as an "antenna" to wirelessly detect blood levels and indicate implant failure. Their results will appear in a forthcoming issue of the Elsevier journal Biosensors and Bioelectronics.

"This is a completely brand new approach to monitoring cerebral embolization and our tests in the lab have been quite successful," says lead author Kenichi Takahata, an assistant professor in the Dept. of Electrical and Computer Engineering and Canada Research Chair whose research areas include micro sensors, smart implants, nanotechnology and wireless microdevices.

"As an early detection method, what we're proposing could be carried out by patients at home on a continual basis," says Takahata, who led the study with UBC postdoctoral fellow Abdolreza Rashidi Mohammadi. "We anticipate having a prototype within two to three years."

Currently, the only way to check whether an embolization is still working is to expose patients to high-dose X-rays for a CT scan or angiography an invasive procedure that involves catheters and injecting dyes to highlight brain arteries. Both methods preclude frequent patient checkups.

Aneurysms can occur in any blood vessel in the body and usually cannot be detected unless there is a rupture or leakage. Aneurysms in the brain are one of the common types, affecting up to six per cent of the population. About 33,000 North Americans suffer a rupture every year, leading to stroke with up to a 60 per cent fatality rate and permanent disability in about 50 per cent of the survivors.


'/>"/>
Contact: Lorraine Chan
lorraine.chan@ubc.ca
604-822-2644
University of British Columbia
Source:Eurekalert

Related biology news :

1. Medical researchers make important research link between active ingredient in saffron and MS
2. BGSU researchers harness power of genome institute for Great Lakes study
3. Caltech researchers find pulsating response to stress in bacteria
4. Researchers pinpoint possible new cause for unexplained miscarriages
5. Savannas, forests in a battle of the biomes, Princeton researchers find
6. Lung regeneration closer to reality with new discovery by Weill Cornell Medical College researchers
7. Researchers build largest protein interaction map to date
8. WSU researchers demonstrate rare animal model for studying depression
9. UC Davis researchers discover complexities of DNA repair
10. Researchers generate first complete 3-D structures of bacterial chromosome
11. Researchers at NYU Langone Medical Center review the microbiome and its possible role in cancers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2017)... 2017 According to a new market research report ... Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region ... expected to grow from USD 14.30 Billion in 2017 to USD 31.75 ... ... MarketsandMarkets Logo ...
(Date:4/6/2017)... Forecasts by Product Type (EAC), ... End-Use (Transportation & Logistics, Government & Public Sector, Utilities ... Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), ... you looking for a definitive report on the $27.9bn ... ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ComplianceOnline’s Medical ... place on 7th and 8th June 2018 in San Francisco, CA. The Summit brings ... well as several distinguished CEOs, board directors and government officials from around the world ...
(Date:10/11/2017)... HILLS, Calif. , Oct. 11, 2017  SkylineDx today ... (ICR) and University of Leeds ... risk-stratify patients with multiple myeloma (MM), in a multi-centric Phase ... University of Leeds is the sponsor ... and ICR will perform the testing services to include high-risk ...
(Date:10/11/2017)... Tampa Bay, Florida (PRWEB) , ... October 11, ... ... Food and Drug Administration (FDA) has granted orphan drug designation to SBT-100, its ... antibody (sdAb) for the treatment of osteosarcoma. SBT-100 is able to cross the ...
(Date:10/10/2017)... , ... October 10, 2017 , ... ... Center’s FirstHand program has won a US2020 STEM Mentoring Award. Representatives of the ... for Excellence in Volunteer Experience from US2020. , US2020’s mission is to change ...
Breaking Biology Technology: